Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Approach to Infantile Spasms: Combined Cosyntropin Injectable Suspension, 1 mg/mL and Vigabatrin Induction Therapy

NCT03347526 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT03347526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03347526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Approach to Infantile Spasms: Combined Cosyntropin Injectable Suspension, 1 mg/mL and Vigabatrin Induction Therapy
Lead sponsor
University of Colorado, Denver
Phase
Phase 3
Overall status
Suspended
Start date
April 19, 2018
Completion date
August 31, 2021
Enrollment
394 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

infantile spasm